SkinBioTherapeutics (SBTX) Competitors GBX 16.50 -0.10 (-0.60%) As of 11:22 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock SBTX vs. CIR, 4BB, BVXP, TILS, VSN, SCLP, MPH, HEMO, OBI, and ORPHShould you be buying SkinBioTherapeutics stock or one of its competitors? The main competitors of SkinBioTherapeutics include Circassia Group (CIR), 4basebio (4BB), Bioventix (BVXP), Tiziana Life Sciences (TILS), Verseon (VSN), Scancell (SCLP), Mereo BioPharma Group plc (MPH.L) (MPH), Hemogenyx Pharmaceuticals (HEMO), Ondine Biomedical (OBI), and Open Orphan (ORPH). These companies are all part of the "biotechnology" industry. SkinBioTherapeutics vs. Its Competitors Circassia Group 4basebio Bioventix Tiziana Life Sciences Verseon Scancell Mereo BioPharma Group plc (MPH.L) Hemogenyx Pharmaceuticals Ondine Biomedical Open Orphan SkinBioTherapeutics (LON:SBTX) and Circassia Group (LON:CIR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk. Do institutionals and insiders believe in SBTX or CIR? 2.3% of SkinBioTherapeutics shares are held by institutional investors. 2.7% of SkinBioTherapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is SBTX or CIR more profitable? Circassia Group has a net margin of 0.00% compared to SkinBioTherapeutics' net margin of -237.95%. Circassia Group's return on equity of 0.00% beat SkinBioTherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SkinBioTherapeutics-237.95% -115.86% -61.18% Circassia Group N/A N/A N/A Which has stronger valuation and earnings, SBTX or CIR? Circassia Group has higher revenue and earnings than SkinBioTherapeutics. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than Circassia Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSkinBioTherapeutics£2.68M15.94-£3.71M-£0.01-1,320.00Circassia Group£27.90M0.00N/A£0.01N/A Does the media favor SBTX or CIR? In the previous week, SkinBioTherapeutics' average media sentiment score of 0.00 equaled Circassia Group'saverage media sentiment score. Company Overall Sentiment SkinBioTherapeutics Neutral Circassia Group Neutral SummaryCircassia Group beats SkinBioTherapeutics on 6 of the 8 factors compared between the two stocks. Get SkinBioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBTX vs. The Competition Export to ExcelMetricSkinBioTherapeuticsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£42.70M£232.82M£5.79B£2.58BDividend YieldN/A3.78%5.61%5.31%P/E Ratio-1,320.0034.95348.895,398.40Price / Sales15.944,487.06522.5597,640.89Price / Cash9.0013.1926.0127.93Price / Book9.83128.4715.538.91Net Income-£3.71M-£90.99M£3.29B£5.89B7 Day Performance0.15%-0.44%200.87%0.56%1 Month Performance13.79%17.81%184.38%2.72%1 Year PerformanceN/A746.82%325.51%198.81% SkinBioTherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBTXSkinBioTherapeuticsN/AGBX 16.50-0.6%N/AN/A£42.70M£2.68M-1,320.0011CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down4BB4basebio1.2874 of 5 starsGBX 800-3.9%GBX 1,600+100.0%-42.9%£130.07M£933K-851.06101BVXPBioventixN/AGBX 2,426-0.6%N/A-37.0%£127.23M£13.66M1,637.8612TILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911Positive NewsVSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpSCLPScancellN/AGBX 10.03-1.2%N/A-32.0%£103.78M£4.71M-482.2151Positive NewsMPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap DownHEMOHemogenyx PharmaceuticalsN/AGBX 1,480-4.2%N/A+100,307.1%£82.30MN/A-817.2314High Trading VolumeOBIOndine BiomedicalN/AC$15.00-3.2%N/A+166.7%C$77.76MC$2.05M-214.29N/APositive NewsGap DownORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179 Related Companies and Tools Related Companies Circassia Group Alternatives 4basebio Alternatives Bioventix Alternatives Tiziana Life Sciences Alternatives Verseon Alternatives Scancell Alternatives Mereo BioPharma Group plc (MPH.L) Alternatives Hemogenyx Pharmaceuticals Alternatives Ondine Biomedical Alternatives Open Orphan Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SBTX) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SkinBioTherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share SkinBioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
